98 related articles for article (PubMed ID: 27247371)
1. Warfarin Pharmacogenetics Reevaluated: Subgroup Analysis Reveals a Likely Underestimation of the Maximum Pharmacogenetic Benefit by Clinical Trials.
Stack G; Maurice CB
Am J Clin Pathol; 2016 May; 145(5):671-86. PubMed ID: 27247371
[TBL] [Abstract][Full Text] [Related]
2. Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans.
Drozda K; Wong S; Patel SR; Bress AP; Nutescu EA; Kittles RA; Cavallari LH
Pharmacogenet Genomics; 2015 Feb; 25(2):73-81. PubMed ID: 25461246
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Maintenance Dose Predictions by Warfarin Dosing Algorithms Based on Chinese and Western Patients.
Deng J; Wang Y; An X
J Clin Pharmacol; 2023 May; 63(5):569-582. PubMed ID: 36546564
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of the pharmacogenetic dosing table in the warfarin label in predicting initial therapeutic warfarin doses in a large, racially diverse cohort.
Shin J; Kayser SR
Pharmacotherapy; 2011 Sep; 31(9):863-70. PubMed ID: 21923587
[TBL] [Abstract][Full Text] [Related]
5. Ensemble of machine learning algorithms using the stacked generalization approach to estimate the warfarin dose.
Ma Z; Wang P; Gao Z; Wang R; Khalighi K
PLoS One; 2018; 13(10):e0205872. PubMed ID: 30339708
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic Warfarin Dosing Algorithms: Validity in Egyptian Patients.
Selim TE; Azzam HA; Ghoneim HR; Mohamed AA; El Wakeel H; Abu Bakr HM
Acta Haematol; 2018; 139(4):255-262. PubMed ID: 29996126
[TBL] [Abstract][Full Text] [Related]
7. Effect of the VKORC1 D36Y variant on warfarin dose requirement and pharmacogenetic dose prediction.
Kurnik D; Qasim H; Sominsky S; Lubetsky A; Markovits N; Li C; Stein CM; Halkin H; Gak E; Loebstein R
Thromb Haemost; 2012 Oct; 108(4):781-8. PubMed ID: 22871975
[TBL] [Abstract][Full Text] [Related]
8. Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testing.
Roper N; Storer B; Bona R; Fang M
J Mol Diagn; 2010 May; 12(3):283-91. PubMed ID: 20228265
[TBL] [Abstract][Full Text] [Related]
9. Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation.
Cho HJ; On YK; Bang OY; Kim JW; Huh W; Ko JW; Kim JS; Lee SY
Clin Ther; 2011 Oct; 33(10):1371-80. PubMed ID: 21981797
[TBL] [Abstract][Full Text] [Related]
10. Failure of pharmacogenetic-based dosing algorithms to identify older patients requiring low daily doses of warfarin.
Schwartz JB; Kane L; Moore K; Wu AH
J Am Med Dir Assoc; 2011 Nov; 12(9):633-8. PubMed ID: 21450231
[TBL] [Abstract][Full Text] [Related]
11. Comparative performance of warfarin pharmacogenetic algorithms in Chinese patients.
Liu Y; Yang J; Xu Q; Xu B; Gao L; Zhang Y; Zhang Y; Wang H; Lu C; Zhao Y; Yin T
Thromb Res; 2012 Sep; 130(3):435-40. PubMed ID: 22374335
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic-Guided Algorithm to Improve Daily Dose of Warfarin in Elder Han-Chinese Population.
Ren Y; Yang C; Chen H; Dai D; Wang Y; Zhu H; Wang F
Front Pharmacol; 2020; 11():1014. PubMed ID: 32754031
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation.
Anderson JL; Horne BD; Stevens SM; Grove AS; Barton S; Nicholas ZP; Kahn SF; May HT; Samuelson KM; Muhlestein JB; Carlquist JF;
Circulation; 2007 Nov; 116(22):2563-70. PubMed ID: 17989110
[TBL] [Abstract][Full Text] [Related]
14. Verification of five pharmacogenomics-based warfarin administration models.
Lin M; Yu L; Qiu H; Wang Q; Zhang J; Song H
Indian J Pharmacol; 2016; 48(3):258-63. PubMed ID: 27298494
[TBL] [Abstract][Full Text] [Related]
15. Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration.
Santos PC; Marcatto LR; Duarte NE; Gadi Soares RA; Cassaro Strunz CM; Scanavacca M; Krieger JE; Pereira AC
Pharmacogenomics; 2015 Jul; 16(8):865-76. PubMed ID: 26050796
[TBL] [Abstract][Full Text] [Related]
16. Validation of warfarin pharmacogenetic algorithms in clinical practice.
Marin-Leblanc M; Perreault S; Bahroun I; Lapointe M; Mongrain I; Provost S; Turgeon J; Talajic M; Brugada R; Phillips M; Tardif JC; Dubé MP
Pharmacogenomics; 2012 Jan; 13(1):21-9. PubMed ID: 22176621
[TBL] [Abstract][Full Text] [Related]
17. Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations.
Wu AH; Wang P; Smith A; Haller C; Drake K; Linder M; Valdes R
Pharmacogenomics; 2008 Feb; 9(2):169-78. PubMed ID: 18370846
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic impact of VKORC1 and CYP2C9 allelic variants on warfarin dose requirements in a hispanic population isolate.
Palacio L; Falla D; Tobon I; Mejia F; Lewis JE; Martinez AF; Arcos-Burgos M; Camargo M
Clin Appl Thromb Hemost; 2010 Feb; 16(1):83-90. PubMed ID: 19567378
[TBL] [Abstract][Full Text] [Related]
19. Genotype-based dosing algorithms for warfarin therapy: data review and recommendations.
Johnson EG; Horne BD; Carlquist JF; Anderson JL
Mol Diagn Ther; 2011 Oct; 15(5):255-64. PubMed ID: 22047153
[TBL] [Abstract][Full Text] [Related]
20. Extremely low warfarin dose in patients with genotypes of CYP2C9*3/*3 and VKORC1-1639A/A.
Gao L; He L; Luo J; Xu B; Yang J; Zhang YX; Yang T; Li K; Tian JW; Wang HJ; Zhao YS; Lu CY; Zhang WZ; Yin T
Chin Med J (Engl); 2011 Sep; 124(17):2767-70. PubMed ID: 22040439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
